RASL10B is a member of the RAS family of genes, which are known to encode small GTPase proteins that play critical roles in various cellular functions including cell growth, cell cycle progression, and cell death. While the RAS gene family is one of the most studied due to its implications in cell signaling, RASL10B itself has garnered interest for its potential involvement in intracellular signaling networks. Unlike its more renowned counterparts, the precise biological functions and regulatory mechanisms of RASL10B remain less defined. However, it is understood that the expression of RASL10B, like many genes, can be responsive to a diverse array of molecular signals, including those from small molecule compounds. These molecules can act as activators, triggering a cascade of cellular events that ultimately lead to the upregulation of RASL10B expression at the transcriptional level.
Research into the regulation of RASL10B has identified several chemical activators that can potentially induce its expression. For example, substances such as retinoic acid and forskolin are known to engage with cellular receptors and enzymes to promote gene expression through well-characterized pathways. Retinoic acid interacts with its nuclear receptors to initiate transcription of specific genes, while forskolin stimulates the production of cyclic AMP, a secondary messenger that activates a host of downstream targets including transcription factors that can bind to promoters like that of RASL10B. Other compounds, such as histone deacetylase inhibitors like trichostatin A and sodium butyrate, act epigenetically to relax chromatin structure, thereby increasing the accessibility of transcriptional machinery to the RASL10B gene. DNA methylation inhibitors, such as 5-azacytidine, induce gene expression by removing methyl groups from DNA, which is often associated with gene silencing. The diversity of these molecules underscores the complexity of gene regulation and the multitude of entry points through which RASL10B expression can be modulated in the cell. It is the intricate interplay between these activators and the cellular environment that dictates the expression patterns of genes like RASL10B, contributing to the dynamic nature of cellular function and the fine-tuning of cellular responses to internal and external stimuli.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid could upregulate RASL10B by binding to its nuclear retinoic acid receptors, leading to the activation of gene transcription specific to RASL10B. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine might initiate the transcription of RASL10B by causing DNA demethylation at the gene's promoter, thus favoring gene expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A has the potential to stimulate RASL10B transcription by inhibiting histone deacetylase, which would result in a more accessible chromatin state at the RASL10B locus. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin could elevate RASL10B levels by activating adenylyl cyclase, leading to an increase in cAMP and subsequent activation of cAMP-dependent transcription factors that target the RASL10B promoter. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate may stimulate the expression of RASL10B by inhibiting histone deacetylases, which would enhance the transcriptional activity within the RASL10B gene region. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin gallate could heighten RASL10B expression by triggering antioxidant response elements within the promoter region of RASL10B, leading to increased transcription. | ||||||
Theophylline | 58-55-9 | sc-202835 sc-202835A sc-202835B | 5 g 25 g 100 g | $20.00 $32.00 $85.00 | 6 | |
Theophylline has the potential to increase RASL10B expression by inhibiting phosphodiesterase, which would raise intracellular cAMP levels and could lead to enhanced transcription of the RASL10B gene. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol could boost RASL10B expression by activating sirtuins and altering the expression of genes involved in cellular stress responses, including those related to the RASL10B pathway. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride might trigger an upsurge in RASL10B expression by inhibiting GSK-3, thereby modifying the transcriptional machinery in favor of RASL10B gene activation. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone could induce the expression of RASL10B by interacting with glucocorticoid receptors, which can bind to glucocorticoid response elements in the RASL10B promoter region. | ||||||